title: Raltegravir for postexposure prophylaxis following occupational exposure to HIV.
authors.forename: Marc O
authors.initials: MO
authors.lastname: Siegel
authors.forename: Virginia L
authors.initials: VL
authors.lastname: Kan
authors.forename: Debra A
authors.initials: DA
authors.lastname: Benator
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control*; D008297:Male; D016273:Occupational Exposure / Q000009:adverse effects*; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium